Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
Active, not recruiting · NCT05333003 · Registry updated 2026-05-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity | Body Weight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Active, not recruiting | Not applicable | 2026-05-27 | NCT05333003 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre for Addiction and Mental Health | 101 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre for Addiction and Mental Health | Toronto | Canada | 26 |